Human salivary microRNAs in Cancer
- PMID: 29556321
- PMCID: PMC5858485
- DOI: 10.7150/jca.21180
Human salivary microRNAs in Cancer
Abstract
Circulating microRNAs (miRNAs) have emerged as excellent candidates for cancer biomarkers. Several recent studies have highlighted the potential use of saliva for the identification of miRNAs as novel biomarkers, which represents a great opportunity to improve diagnosis and monitor general health and disease. This review summarises the mechanisms of miRNAs deregulation in cancer, the value of targeting them with a therapeutic intention and the evidence of the potential clinical use of miRNAs expressed in saliva for the detection of different cancer types. We also provide a comprehensive review of the different methods for normalising the levels of specific miRNAs present in saliva, as this is a critical step in their analysis, and the challenge to validate salivary miRNAs as a reality to manage cancer patients.
Keywords: biomarkers; cancer; liquid biopsy; miRNAs; normalization; saliva.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures
References
-
- Kishore L, Kaur N, Singh R. Distinct biomarkers for early diagnosis of diabetic nephropathy. Curr Diabetes Rev. 2017;13(6):598–605. [Epub ahead of print] - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
